Rare diseases
Investigational molecules
Locations
Back to Germany1 191 clinical trials in Munich, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
GermanyStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
GermanyStudy on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
GermanyGermanyStudy of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer
GermanyStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
GermanyStudy of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
GermanyStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
GermanyStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
GermanyEfficacy and Safety of E2086 in Adults with Narcolepsy: A Randomized, Double‑Blind, Placebo‑Controlled Trial
GermanyDose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on various cancer types, including metastatic prostate cancer, colorectal cancer, and bladder cancer. Novel therapeutic approaches combining immunotherapy with established treatments are being investigated.
Research aims to improve survival rates and treatment effectiveness through targeted therapies and immunological approaches.
Important research in heart disease and blood conditions, including studies on TTR amyloidosis and prevention of thrombotic events. Novel medications are being tested to improve patient outcomes.
Focus on developing innovative treatments for complex cardiovascular conditions and preventing blood clots.
Advanced research into neurological conditions, particularly focusing on Alzheimer's disease and autoimmune dementia. Studies aim to develop new therapeutic approaches and improve diagnostic tools.
Innovative approaches to treating and managing neurodegenerative conditions.
Critical research in HIV prevention and immune system modulation, including studies on transplant medicine and vaccine development for yellow fever.
Focus on preventing infectious diseases and improving transplant outcomes through immunological interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
